Drug reference

tlk199

Glutathione analogue

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

TLK199 is a prodrug that plasma esterases convert to TLK117, an active glutathione S-transferase (GST) inhibitor, which potentiates the toxicity of different anticancer agents.

Ask House about tlk199

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team